Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:7
  • preuzimanja u poslednjih 30 dana:2

Sadržaj

članak: 3 od 25  
Back povratak na rezultate
2019, vol. 76, br. 2, str. 152-160
Kompletna perkutana revaskularizacija miokarda kod bolesnika sa STEMI komplikovanim kardiogenim šokom
aUniverzitet u Novom Sadu, Medicinski fakultet + Univerzitet u Novom Sadu, Medicinski fakultet, Institut za kardiovaskularne bolesti
bUniverzitet u Novom Sadu, Medicinski fakultet, Institut za kardiovaskularne bolesti
cUniverzitet u Novom Sadu, Medicinski fakultet

e-adresamilovan.petrovic@mf.uns.ac.rs
Sažetak
Uvod/Cilj. I pored značajnog napretka rane miokardne revaskularizacije i upotrebe mehaničke cirkulatorne podrške, kardiogeni šok i dalje predstavlja vodeći uzrok smrti kod akutnog infarkta miokarda. Aktuelne preporuke Evropskog udruženja kardiologa preporučuju ranu revaskularizaciju svih kritičnih stenoza ili visoko nestabilnih lezija kod stanja kardiogenog šoka, dok skorašnje studije preporučuju ranu revaskularizaciju samo infarktne koronarne arterije kod bolesnika sa akutnim infarktom miokarda sa ST segment elevacijom (STEMI) i kardiogenim šokom. Cilj studije bio je da analizira uticaj kompletne rane perkutane miokardijalne revaskularizacije u akutnom infarktu komplikovanim kardiogenim šokom na intrahospitalni mortalitet. Metode. Istraživanje je sprovedeno kao retrospektivna opservaciona analiza podataka dobijenih iz bolničkih registara za kardiogeni šok. Studijska grupa imala je 235 bolesnika lečenih u periodu od avgusta 2007. do oktobra 2016. godine zbog STEMI komplikovanim kardiogenim šokom. Formirane su tri grupe. Prva grupa sastojala se od bolesnika sa bolešću jednog krvnog suda podvrgnutih revaskularizaciji, arterije povezane sa infarktom. Drugu grupu činili su bolesnici sa multisudovnom bolešću, kod kojih je samo revasulizirana culprit lezija, a treću grupu činili su bolesnici sa multi-sudovnom bolešću i kompletnom revaskularizacijom miokarda. Dodatne subgrupe formirane su na osnovu implantaciju intraaortne balon pumpe (IABP). Intrahospitalni mortalitet analiziran je u svim grupama i subgrupama. Rezultati. Revaskulsrizacija samo culprit lezije kod bolesnika sa multisudovnom bolešću učinjena je kod 142 (60,4%) bolesnika, dok je kompletna revaskularizacija (revaskularizacija culprit i ostalih značajnih lezija) kod bolesnika sa multisudovnim lezijama učinjena kod 28 (11,9%) bolesnika. Šezdeset pet (27,7%) bolesnika sa jednosudovnom bolešću podvrgnuto je revaskularizaciji infarktne arterije. Najniži mortalitet bio je u grupi bolesnika sa multisudovnom koronarnom bolešću koji su podvrgnuti kompletnoj revaskularizaciji i implantaciji IABP (mortalitet 35,7%). Razlika u srednjoj vrednosti ejekcione frakcije leve komore (EF) između preživelih i umrlih bila je statistički značajna (p < 0,005). Prosečna vrednost EF kod preživelih bila je 44% (35%-50%), dok je kod umrlih iznosila 30% (25%-39,5%). Na osnovu korišćenih podataka, testiran je matematički prediktivni model. Reciever operating characteristics (ROC) kriva pokazala je da je naš model dobar pokazatelj fatalnog ishoda (p < 0,0005; AUROC = 0,766), uz senzitivnost od 80,3% i specifičnost 67%. Zaključak. STEMI komplikovan kardiogenim šokom još uvek je udružen sa visokom stopom mortaliteta. Samo kompletna revaskularizacija miokarda, kao i u kombinaciji sa IABP, značajno smanjuje mortalitet kod bolesnika sa akutnim STEMI komplikovanim kardiogenim šokom.
Reference
Babaev, A., Frederick, P.D., Pasta, D.J., Every, N., Sichrovsky, T., Hochman, J.S., NRMI, I.for the (2005) Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA, 294(4): 448
Bonnow, R.O., Mann, DL., Zipes, D.P., Libby, P. (2011) Braunwald's heart disease: A textbook of cardiovascular medicine. Philadelphia: Elsevier Science, 9th ed
Filho, F.H.F., Conejo, F., Santos, L.N.dos, Campos, C.A., Neto, P.A.L. (2013) In-hospital Outcomes of Patients with Cardiogenic Shock due to ST-Segment Elevation Myocardial Infarction. Revista Brasileira de Cardiologia Invasiva (English Edition), 21(3): 265-269
Garcia-Alvarez, A., Arzamendi, D., Loma-Osorio, P., Kiamco, R., Masotti, M., Sionis, A., Betriu, A., Brugada, J., Bosch, X. (2009) Early Risk Stratification of Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention. American Journal of Cardiology, 103(8): 1073-1077
Gershlick, A.H., Khan, J.N., Kelly, D.J., Greenwood, J.P., Sasikaran, T., Curzen, N., i dr. (2015) Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol, 65(10): 963-72
Goldberg, R.J., Spencer, F.A., Gore, J.M., Lessard, D., Yarzebski, J. (2009) Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction. Circulation, 119(9): 1211-1219
Goldberg, R.J., Samad, N.A., Yarzebski, J., Gurwitz, J., Bigelow, C., Gore, J.M. (1999) Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction. New England Journal of Medicine, 340(15): 1162-1168
Ibanez, B., James, S., Agewall, S., Antunes, M.J., Bucciarelli-Ducci, K., Bueno, H., i dr. (2018) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the ESC. Eur Heart J, 39(2): 119-77
Ibrahim, H., Sharma, P.K., Cohen, D.J., Fonarow, G.C., Kaltenbach, L.A., Effron, M.B., Zettler, M.E., Peterson, E.D., Wang, T.Y. (2017) Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study. Journal of the American Heart Association, 6(10):
Institute of Public Health of Serbia Dr Milan Jovanović Batut (2015) Incidence and mortality of acute coronary syndrome in Serbia. u: Serbian Acute Coronary Syndrome Registry: Report No. 10, Belgrade
Kolte, D., Khera, S., Aronow, W.S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Gotsis, W., Ahmed, A., Frishman, W.H., Fonarow, G.C. (2014) Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States. Journal of the American Heart Association, 3(1):
Leor, J., Goldbourt, U., Reicher-Reiss, H., Kaplinsky, E., Behar, S. (1993) Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome. American Journal of Medicine, 94(3): 265-273
Levine, G.N., Bates, E.R., Blankenship, J.C., Bailey, S.R., Bittl, J.A., Cercek, B., i dr. (2016) ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With STElevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for t. J Am Coll Cardiol, 67(10): 1235-50
Lindholm, M. (2003) Cardiogenic shock complicating acute myocardial infarction Prognostic impact of early and late shock development. European Heart Journal, 24(3): 258-265
Longo, DL., Fauci, A.S., Kasper, DL., Hauser, S.L., Jameson, J.L., Loscalzo, J. (2012) Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 18th ed
Mehta, R.H., Ou, F., Peterson, E.D., Shaw, R.E., Hillegass, W.B., Rumsfeld, J.S., Roe, M.T. (2009) Clinical Significance of Post-Procedural TIMI Flow in Patients With Cardiogenic Shock Undergoing Primary Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 2(1): 56-64
Menon, V., Fincke, R. (2012) Cardiogenic Shock: A Summary of the Randomized SHOCK Trial. Congestive Heart Failure, 9(1): 35-39
Rasoul, S., Ottervanger, J.P., de Boer, M., Dambrink, J.E., Hoorntje, J.C.A., Marcel, G.A.T., Zijlstra, F., Suryapranata, H., van ʼt Hof, A.W.J. (2009) Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coronary Artery Disease, 20(6): 415-421
Sorajja, P., Gersh, B. J., Cox, D. A., McLaughlin, M. G., Zimetbaum, P., Costantini, C., Stuckey, T., Tcheng, J. E., Mehran, R., Lansky, A. J., Grines, C. L., Stone, G. W. (2007) Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. European Heart Journal, 28(14): 1709-1716
The, T.I. (2007) Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic Shock. JAMA, 297(15): 1657
Thiele, H., Allam, B., Chatellier, G., Schuler, G., Lafont, A. (2010) Shock in acute myocardial infarction: the Cape Horn for trials?. European Heart Journal, 31(15): 1828-1835
Thiele, H., Akin, I., Sandri, M., Fuernau, G., de Waha, S., Meyer-Saraei, R., Nordbeck, P., Geisler, T., Landmesser, U., Skurk, C., Fach, A., Lapp, H., Piek, J.J., Noc, M., Goslar, T., Felix, S.B. (2017) PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. New England Journal of Medicine, 377(25): 2419-2432
Thiele, H., Zeymer, U., Neumann, F., Ferenc, M., Olbrich, H., Hausleiter, J., de Waha, A., Richardt, G., Hennersdorf, M., Empen, K., Fuernau, G., Desch, S., Eitel, I., Hambrecht, R., Lauer, B. (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet, 382(9905): 1638-1645
Thiele, H., Zeymer, U., Neumann, F., Ferenc, M., Olbrich, H., Hausleiter, J., Richardt, G., Hennersdorf, M., Empen, K., Fuernau, G., Desch, S., Eitel, I., Hambrecht, R., Fuhrmann, J., Böhm, M. (2012) Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. New England Journal of Medicine, 367(14): 1287-1296
Toma, M., Buller, C. E., Westerhout, C. M., Fu, Y., o'Neill W. W., Holmes, D. R., Hamm, C. W., Granger, C. B., Armstrong, P. W. (2010) Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. European Heart Journal, 31(14): 1701-1707
Vincent, J., de Backer, D. (2013) Circulatory Shock. New England Journal of Medicine, 369(18): 1726-1734
Wald, D.S., Morris, J.K., Wald, N.J., Chase, A.J., Edwards, R.J., Hughes, L.O., Berry, C., Oldroyd, K.G. (2013) Randomized Trial of Preventive Angioplasty in Myocardial Infarction. New England Journal of Medicine, 369(12): 1115-1123
Windecker, S., i dr. (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 35(37): 2541-2619
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.2298/VSP180128183P
objavljen u SCIndeksu: 25.04.2019.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0